Lexicon Pharmaceuticals | LXRX - القيمة السوقية





القيمة السوقية تغيير تاريخ
Abbott USD 158.05B 20.36B 2026-06
Acadia Pharmaceuticals USD 4.33B 537M 2026-06
Akebia Therapeutics USD 427M 297M 2025-12
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
AstraZeneca USD 289.99B 11.26B 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 1.13T 260.54B 2026-06
Halozyme Therapeutics USD 9.28B 1.63B 2026-06
Illumina USD 26.71B 8.84B 2026-06
Insmed USD 23.11B 12.19B 2026-06
J&J USD 611.36B 32.21B 2026-06
Lexicon Pharmaceuticals USD 418M 73M 2025-12
MacroGenics USD 184M 82M 2026-03
MannKind USD 1.32B 559M 2026-06
Merck USD 317.37B 20.27B 2026-06
Novartis USD 240.59B 67.17B 2026-06
Sarepta Therapeutics USD 1.9B 388M 2026-06
Thermo Fisher Scientific USD 190.65B 7.99B 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
United Therapeutics USD 23B 2.19B 2026-06
Vanda Pharmaceuticals USD 279M 6M 2024-12